Genflow Biosciences reports primary endpoint in SLAB clinical trial
Genflow Biosciences PLC said it has a primary endpoint in its SLAB clinical trial, in an RNS published 08 September 2026.
RNS Number: 7471T Genflow Biosciences PLC 08 September 2026 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEA…